We have high confidence MJFF will renew their grant since The most recent test results came back very positive, so AMBS has advanced greatly since MJFF issued previous grant.
Nobody is confirming an MJFox grant on Feb 20. The possibility is there. The difference between us longs and the nay sayers is that us longs wouldn't be posting on this board if we didn't have something positive to say about AMBS. There for the longs are honest and the negative ppl are not. Please don't reply because I won't read it.
The lead MANF product development effort is centered on a therapy for Parkinson's disease, currently funded by a research grant from the Michael J. Fox Foundation for Parkinson’s Research. The Company also owns an inventory of 88 cell lines referred to as “PhenoGuard Cell Lines.” MANF was the first therapeutic protein discovered from a PhenoGuard Cell Line. It is anticipated that additional therapeutic proteins useful for various therapeutic approaches to the Central Nervous System will be identified from the Company’s inventory of PhenoGuard Cell Lines.
News 
Market Data 
Discover 
